OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cardiovascular and renal outcomes with SGLT2 inhibitors: Real-life observational studies in older patients with type 2 diabetes
André Scheen
Diabetes Epidemiology and Management (2023) Vol. 10, pp. 100135-100135
Open Access | Times Cited: 5
André Scheen
Diabetes Epidemiology and Management (2023) Vol. 10, pp. 100135-100135
Open Access | Times Cited: 5
Showing 5 citing articles:
Comparative cardiovascular effectiveness of newer glucose-lowering drugs in elderly with type 2 diabetes: a target trial emulation cohort study
Vanja Kosjerina, Mojtaba Parsa, Stine H. Scheuer, et al.
EClinicalMedicine (2025) Vol. 82, pp. 103162-103162
Closed Access
Vanja Kosjerina, Mojtaba Parsa, Stine H. Scheuer, et al.
EClinicalMedicine (2025) Vol. 82, pp. 103162-103162
Closed Access
Dapagliflozin in Elderly Care
Sameer Angurana, Kiranpreet Kaur, Baldeep Kaur, et al.
Journal of The Indian Academy of Geriatrics (2025) Vol. 21, Iss. 1, pp. 71-74
Open Access
Sameer Angurana, Kiranpreet Kaur, Baldeep Kaur, et al.
Journal of The Indian Academy of Geriatrics (2025) Vol. 21, Iss. 1, pp. 71-74
Open Access
Cost‐effectiveness of canagliflozin and dapagliflozin for treatment of patients with chronic kidney disease and type 2 diabetes
Bao N. Nguyen, Shweta Mital, Shawn Bugden, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 10, pp. 3030-3039
Closed Access | Times Cited: 10
Bao N. Nguyen, Shweta Mital, Shawn Bugden, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 10, pp. 3030-3039
Closed Access | Times Cited: 10
The current role of SGLT2 inhibitors in type 2 diabetes and beyond: a narrative review
André Scheen
Expert Review of Endocrinology & Metabolism (2023) Vol. 18, Iss. 4, pp. 271-282
Closed Access | Times Cited: 9
André Scheen
Expert Review of Endocrinology & Metabolism (2023) Vol. 18, Iss. 4, pp. 271-282
Closed Access | Times Cited: 9
Real-life underuse of SGLT2 inhibitors for patients with type 2 diabetes at high cardiorenal risk
André Scheen
Diabetes Epidemiology and Management (2023) Vol. 13, pp. 100184-100184
Open Access | Times Cited: 9
André Scheen
Diabetes Epidemiology and Management (2023) Vol. 13, pp. 100184-100184
Open Access | Times Cited: 9
Incidence of stroke, subsequent clinical outcomes and health care resource utilization in people with type 2 diabetes: a real-world database study in France: “INSIST” study
Kamel Mohammedi, Laurent Fauchier, Nadia Quignot, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Kamel Mohammedi, Laurent Fauchier, Nadia Quignot, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 3
